Eric Ende
Chairman at MATINAS BIOPHARMA HOLDINGS, INC.
Net worth: 6 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Roelof Rongen | M | 59 |
Matinas BioPharma, Inc.
| 13 years |
Jerome Jabbour | M | 50 |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | 11 years |
Herbert Conrad | M | 91 | 11 years | |
Gregory Divis | M | 57 | 7 years | |
Todd Branning | M | 54 | 2 years | |
Kathryn Corzo | F | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
Jerad G. Seurer | M | - | 7 years | |
Stefano Ferrari | M | 55 |
Matinas BioPharma, Inc.
| 12 years |
Geoffrey Glass | M | 50 | 6 years | |
David Mims | M | 60 | 5 years | |
George Bobotas | M | 76 |
Matinas BioPharma, Inc.
| 13 years |
Matthew Wikler | M | 74 | 6 years | |
Mark McCamish | M | 72 | 5 years | |
Theresa Matkovits | M | 56 | 6 years | |
James Scibetta | M | 59 | 11 years | |
Linda Palczuk | F | 62 | 6 years | |
Natasha Giordano | F | 62 | 4 years | |
Abdel A. Fawzy | M | 73 |
Matinas BioPharma, Inc.
| 13 years |
Peter Thornton | M | 59 | 7 years | |
Hui Liu | M | 56 | 4 years | |
Angela Woods | F | - | 3 years | |
Denise Strauss | F | - | 3 years | |
Keith Kucinski | M | 55 | 5 years | |
Rangarajan Sundaram | M | 62 |
The Leonard N Stern School of Business
| 28 years |
Stephen G. Ryan | M | 65 |
The Leonard N Stern School of Business
| 29 years |
Jason Vaughn | M | - | 5 years | |
Richard Kim | M | 54 | 3 years | |
Jennifer Gudeman | M | - | 4 years | |
Maghsoud Dariani | M | - |
Mesa Therapeutics, Inc.
| - |
James Ferguson | M | 70 | 5 years | |
Thomas Hoover | M | 55 | 3 years | |
Daniel Moros | M | - |
Icahn School of Medicine at Mount Sinai
| 33 years |
Thomas McHugh | M | 59 | 5 years | |
Steven R. Goldstein | M | 73 |
New York University
| 29 years |
Scott Macke | M | - | 10 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark Robert Baker | M | 69 | 14 years | |
Michael F. Kanan | M | 61 | 4 years | |
Nicole S. Williams | F | 79 | 12 years | |
Andrey Valentin Krakovsky | M | - |
New York University
| - |
Michael Shannon Anderson | M | 75 | 7 years | |
Craig R. Stapleton | M | 79 | 8 years | |
Patrick Fabbio | M | 56 | 5 years | |
Karen Ferrante | M | 66 | 6 years | |
Pat LePore | M | 69 | 3 years | |
Michael B. Weiss | M | - |
Emory University
| 4 years |
John Calaba | M | - |
New York University
| 13 years |
Glenn Perillo | M | - |
The Leonard N Stern School of Business
| 5 years |
Pat M. Patalino | M | - |
New York University
| 3 years |
Thomas Lee | M | - |
The Leonard N Stern School of Business
| 8 years |
Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Sok-Ho Jung | M | 59 |
New York University
| 6 years |
Eitan Leger | M | - |
New York University
| 11 years |
Mary Heino | F | 64 | - | |
Phillandas T. Thompson | M | 50 | 7 years | |
Gary Gaglione | M | 72 | 5 years | |
Geoffrey Bedrosian | M | 58 |
New York University
| - |
Dhiren D'silva | M | - | 4 years | |
Lauren Stival | F | - | 2 years | |
Kevin McNally | M | 55 |
The Leonard N Stern School of Business
New York University
| 3 years |
Dominick DiPaolo | M | 49 | 1 years | |
Claudia Maria Amelia Copper Fort | F | 56 |
New York University
| 5 years |
Jon Solodar | M | - |
Emory University
New York University
| 7 years |
Richard P. Prestegaard | M | - |
The Leonard N Stern School of Business
New York University
| 2 years |
Giovanni Caruso | M | - |
New York University
| 7 years |
Nicolo Antonio Celentano | M | - |
The Leonard N Stern School of Business
New York University
| 2 years |
Lewis McKay Johnson | M | 54 |
Emory University
| 4 years |
Susan Potto | F | - |
Emory University
New York University
| 7 years |
David Scheinberg | M | 68 | 25 years | |
Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
Bradley Campbell | M | 48 | 4 years | |
Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Mark Irvin Allen | M | - |
The Leonard N Stern School of Business
New York University
| 2 years |
Ann MacDougall | F | 70 | 1 years | |
Ralph J. Divino | M | - |
New York University
| 4 years |
Baylor A. Lancaster-Samuel | F | - |
New York University
| 4 years |
Mark Todtfeld | M | - |
Emory University
The Leonard N Stern School of Business
| 7 years |
Damian Georgino | M | 63 |
Emory University
| 3 years |
Richard S. Egosi | M | 61 |
Emory University
| 5 years |
William Mann | M | 63 | 2 years | |
Jonathan Isaac Dubroff | M | - |
The Leonard N Stern School of Business
| 8 years |
William H Haemmerle | M | - |
New York University
| 2 years |
David Moran | M | - |
New York University
| 2 years |
Alfred Lerman | M | - |
New York University
| 4 years |
Susana Gladys Hernandez | F | - |
New York University
| 2 years |
Steinthal Tom | M | - |
New York University
| 4 years |
Jackie Williams | F | - |
New York University
| 3 years |
Kan Zhou | M | - |
New York University
| 6 years |
Sam Nevin | M | - |
New York University
| 3 years |
Frederick Jiang | M | - |
New York University
| 2 years |
Wallace Enman | M | - |
New York University
| 4 years |
Bruce F. Mackle | M | - |
New York University
| 2 years |
Brian P. Donlin | M | - |
New York University
| 4 years |
Seth Rosenfield | M | - |
New York University
| 3 years |
Greg Gorelik | M | - |
New York University
| 4 years |
Romas Garbaliauskas | M | - |
New York University
| 1 years |
Herb Chen | M | - |
New York University
| 4 years |
Steven Grin | M | - |
New York University
| 4 years |
Ophir Shahaf | M | 57 |
New York University
| 2 years |
Rami Branitzky | M | - |
New York University
| 2 years |
Eric Greenspan | M | - |
New York University
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 81 | 81.00% |
Ireland | 19 | 19.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Ende
- Personal Network